A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
In this video, David A. Eichenbaum, MD, FASRS, discusses late-stage wet age-related macular degeneration assets presented at the American Academy of Ophthalmology meeting.Eichenbaum noted that ...
No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety ...
Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.
What is laser photocoagulation? A laser procedure that seals leaking blood vessels to slow vision loss in wet age-related ...
According to Liu, his preferred option is faricimab, a fairly new agent that was FDA-approved for wet AMD in 2022. The drug ...
Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and ...
The use of GLP-1 receptor agonists was associated with a substantially lower long-term risk for dry age-related macular degeneration (AMD) than the use of other weight-loss medications in adults with ...
The study included patients with T2DM ages 50 and older who had been taking metformin and initiated additional therapy with SGLT2 inhibitors or DPP-4 inhibitors. Participants were matched 1:1 (20,966 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback